Association of Helicobacter pylori and gastric atrophy with adenocarcinoma of the esophagogastric junction in Taixing, China
- 9 September 2021
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 150 (2) , 243-252
Abstract
Gastric atrophy caused by Helicobacter pylori infection was suggested to influence the risk of adenocarcinoma of the esophagogastric junction (AEGJ), however, the evidence remains limited. We aimed to examine the associations of H. pylori infection and gastric atrophy (defined using serum pepsinogen [PG] I to PGII ratio) with AEGJ risk, based on a population‐based case‐control study in Taixing, China (2010‐2014), with 349 histopathologically confirmed AEGJ cases and 1859 controls. We explored the potential effect modification by H. pylori serostatus and sex on the association of serum PGs with AEGJ risk. We used unconditional logistic regression models to estimate odds ratios (ORs) and 95% confidence intervals (CIs). H. pylori seropositivity was associated with an elevated AEGJ risk (OR = 1.95, 95% CI: 1.47‐2.63). Neither CagA‐positive nor VacA‐positive strains dramatically changed this association. Gastric atrophy (PGI/PGII ratio ≤4) was positively associated with AEGJ risk (OR = 2.36, 95% CI: 1.72‐3.22). The fully adjusted ORs for AEGJ progressively increased with the increasing levels of PGII (P‐trend <.001). H. pylori showed nonsignificant effect modification (P‐interaction = .385) on the association of gastric atrophy with AEGJ. In conclusion, H. pylori and gastric atrophy were positively associated with AEGJ risk. These results may contribute evidence to the ongoing research on gastric atrophy‐related cancers and guide the prevention and control of AEGJ.Keywords
Funding Information
- National Basic Research Program of China (2016YFC0901403, 2017YFC0907000, 2019YFC1315804)
- National Natural Science Foundation of China (81973116, 82030101, 82073637, 91846302)
This publication has 48 references indexed in Scilit:
- Helicobacter pyloriinfection and esophageal cancer risk: An updated meta-analysisWorld Journal of Gastroenterology, 2013
- Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study CohortBritish Journal of Cancer, 2011
- Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma—a systematic review and meta-analysisAnnals of Oncology, 2010
- Helicobacter pylori: gastric cancer and beyondNature Reviews Cancer, 2010
- Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohortGut, 2009
- Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori statusGut, 2007
- Inflammation, atrophy, and gastric cancerJournal of Clinical Investigation, 2007
- Helicobacter pylori and oesophageal and gastric cancers in a prospective study in ChinaBritish Journal of Cancer, 2006
- Opposing Risks of Gastric Cardia and Noncardia Gastric Adenocarcinomas Associated With Helicobacter pylori SeropositivityJNCI: Journal of the National Cancer Institute, 2006
- Helicobacter pylori and gastrointestinal tract adenocarcinomasNature Reviews Cancer, 2002